Saatvik Green Energy cell ramp-up targets margin recovery despite weak first-quarter volumes

Investment View and Valuation

Motilal Oswal Financial Services maintained its Buy view on Saatvik Green Energy Limited (SGEL) in its August 15, 2026, 1QFY27 result update. The central catalyst is the ramp-up of SGEL's 2.4GW cell-manufacturing capacity in Odisha, which the broker expects to support a substantial improvement in EBITDA margins.

The target price is Rs 508 per share, derived by valuing domestic modules at 8x FY28E EBITDA and adjusting for net debt. This implies an 18 per cent upside from the report's CMP of Rs 431.

Weak 1QFY27 Financial and Operating Performance

SGEL reported a weak 1QFY27, with lower revenue, profitability and module utilisation.

Reasons for the Weak Quarter

Management attributed the weak quarter to lower volumes, as customers deferred procurement under a wait-and-watch approach pending clarity on ALMM-II. Geopolitical and supply-chain disruption, commodity-price volatility, elevated logistics costs and foreign-exchange fluctuations also affected operations.

Margin pressure reflected the absence of in-house cells, intense competition in non-DCR modules, higher input costs and logistics expenses. Management said it remained selective in order execution, prioritising profitable orders amid difficult market conditions.

Cell and Module Capacity Ramp-Up

Management expects ALMM-II inspection in September 2026, with cell production beginning in 3QFY27 and approximately 80 per cent utilisation by 4QFY27. The 4GW module facility is also nearing production ramp-up. Co-locating cell and module manufacturing is expected to provide integration and supply-chain benefits.

Phase 2 would add 3.6GW of cell capacity, taking total cell capacity to 6GW by FY28-end. Phase 3 envisages 6GW of ingot and wafer capacity, with commercial operations targeted in FY29. Management also plans to expand encapsulant capacity to 5GW.

Order Book and Business Mix

The order book was 6.35GW, valued at around Rs 82,000 million and expected to be executed over 12 to 18 months. It comprised around 30 per cent DCR and 70 per cent non-DCR orders. Utility projects accounted for around 70 per cent of the mix, while C&I/open-access projects accounted for 30 per cent.

Management expects DCR orders to earn 18-20 per cent margins using a mix of in-house and external cells. Non-solar module businesses contributed 4-5 per cent of business, with management targeting 7-10 per cent in FY27 and about 15 per cent in FY28.

FY27 Guidance and Broker Estimates

Management guided for FY27 sales of 3.5-4GW, revenue of around Rs 60,000 million, EBITDA margin of around 12 per cent and PAT margin of 6-7 per cent. Motilal Oswal is more conservative, modelling an FY27 EBITDA margin of 8 per cent.

Following the weak quarter and earnings-call guidance, the broker reduced its FY27/FY28 estimates as follows:

• Module-volume estimates were reduced by 5 per cent and 3 per cent, respectively.
• Cell-volume estimates were reduced by 20 per cent and 2 per cent, respectively.
• DCR and non-DCR pricing assumptions were reduced.
• FY27/FY28 adjusted PAT estimates were cut by 34 per cent and 11 per cent, respectively.

The broker expects 2QFY27 earnings to remain under pressure, with substantial margin improvement only in 2HFY27 as cell capacity ramps up.

Key Monitorables and Capital Structure

Key monitorables are the cell-capacity ramp-up, order momentum and pricing across DCR and non-DCR modules, order-book mix, margin recovery and the scaling of non-solar businesses.

Debt stood at around Rs 12,500 million, with debt-to-equity of 0.99x. Phase 1 capex was estimated at Rs 18,500 million, while Phase 2 requires a further Rs 16,000-17,000 million.